ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 Top Breaking News
 Monday, July 28, 2014




 Yesterday's Most Popular News 
Amgen (AMGN), Bayer HealthCare (BAY)'s Nexavar Fails Late-Stage Breast Cancer Study

Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen

Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding

Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study

Kidney Dialysis Drug Phase 3 Data Boost Keryx Biopharmaceuticals (KERX)'s Hopes For U.S. Approval

Newly Discovered Gut Virus Lives In Half The World's Population, San Diego State University Study

Losing Your Job Could Kill You, But Recessions Could Be Good For Your Health, Drexel University And University of Michigan Study

Puma Biotechnology (PBYI) Shares Soar On Breast Cancer Drug Results

GlaxoSmithKline (GSK) Seeks Approval For First Ever Malaria Vaccination

Paracetamol Does Not Work For Lower Back Pain, University of Sydney Study


 
-

 Featured Stories
 
Why Men Like Nice Women And Why Women Like Bad Boys, University of Rochester Study
Slow Walking Speed And Memory Issues Linked To Early Signs Of Dementia, Albert Einstein College of Medicine Study
Shift Work Linked To Heightened Risk Of Type 2 Diabetes, Occupational & Environmental Medicine Reveals
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study
Newly Discovered Gut Virus Lives In Half The World's Population, San Diego State University Study
Losing Your Job Could Kill You, But Recessions Could Be Good For Your Health, Drexel University And University of Michigan Study
Pain And Itch May Be Signs Of Skin Cancer, Temple University School Of Medicine's Chair Of Dermatology Reveals
Paracetamol Does Not Work For Lower Back Pain, University of Sydney Study
More Featured Stories

  Today's Top Jobs

 Featured Employer
About Genzyme Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Learn more at www.jobsatgenzyme.com. Follow our jobs on Twitter www.twitter.com/genzymejobs. Follow us on LinkedIn http://www.linkedin.com/company/genzyme. About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Show me jobs for this employer

 Careers
 
More Career Tips